Literature DB >> 22467326

Imbalance of circulating T-lymphocyte subpopulation in COPD and its relationship with CAT performance.

Cheng Chen1, Yu Shen, Chong-Jun Ni, Ye-Han Zhu, Jian-An Huang.   

Abstract

Chronic obstructive pulmonary disease (COPD) is associated with systemic effects, and T-cell-mediated immunity was involved in the COPD. COPD Assessment Test (CAT) could provide a valid, reliable, and standardized measure of COPD health status. The objective of this study was determination of lymphocyte subpopulation in patients with stable COPD (n = 52) and to ascertain if a relationship existed between T-lymphocyte subpopulation and CAT performance. The stable COPD patients were assessed with CAT, and divided into four groups with score >30 (n = 8), 20< score ≤30 (n = 16), 10< score ≤20 (n = 20), and score ≤10 (n = 8). Spearman's rank correlation was used to determine the relationship between proportion of T lymphocyte and CAT score. We found an elevated proportion of CD8(+) cells in COPD patients of the group with score >30 compared to other groups. Proportion of CD4(+) cells was significantly lower in the groups with score >30 and 20< score ≤30 when compared to groups with 10< score ≤20 and score ≤10. The CD4(+) :CD8(+) ratio was also significantly lower in the groups with score >30 and 20< score ≤30. Of note are the correlations of proportion of CD8(+) cells and CD4(+) :CD8(+) ratio with CAT performance when score >20. No correlations existed between proportion of CD4(+) , CD8(+) cells, CD4(+) :CD8(+) ratio, and CAT performance when score ≤20. Our results show that the determinants of T-lymphocyte subpopulation in COPD patients were value to assess physical conditions. We considered CD4(+) and CD8(+) T lymphocytes to be a representative and stable parameter in grading of health status in COPD patients.
© 2012 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22467326      PMCID: PMC6807605          DOI: 10.1002/jcla.21490

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  16 in total

1.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

2.  Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD.

Authors:  Joanna Domagała-Kulawik; Grazyna Hoser; Marta Dabrowska; Ryszarda Chazan
Journal:  Respir Med       Date:  2006-11-21       Impact factor: 3.415

Review 3.  Nutrition and the immune system.

Authors:  R K Chandra
Journal:  Proc Nutr Soc       Date:  1993-02       Impact factor: 6.297

Review 4.  The assessment of health status among patients with COPD.

Authors:  J R Curtis; D L Patrick
Journal:  Eur Respir J Suppl       Date:  2003-06

5.  Imbalance of circulating dendritic cell subsets in chronic obstructive pulmonary disease.

Authors:  Mario Galgani; Immacolata Fabozzi; Francesco Perna; Dario Bruzzese; Barbara Bellofiore; Cecilia Calabrese; Alessandro Vatrella; Domenico Galati; Giuseppe Matarese; Alessandro Sanduzzi; Marialuisa Bocchino
Journal:  Clin Immunol       Date:  2010-07-14       Impact factor: 3.969

6.  Nutritional status in relation to respiratory impairment and systemic inflammation in patients with acute exacerbations of COPD.

Authors:  Peter Skyba; Zuzana Kluchova; Pavol Joppa; Darina Petrasova; Ruzena Tkacova
Journal:  Med Sci Monit       Date:  2009-10

7.  Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.

Authors:  Toru Oga; Koichi Nishimura; Mitsuhiro Tsukino; Susumu Sato; Takashi Hajiro
Journal:  Am J Respir Crit Care Med       Date:  2002-11-21       Impact factor: 21.405

8.  The Severe Respiratory Insufficiency Questionnaire was valid for COPD patients with severe chronic respiratory failure.

Authors:  Wolfram Windisch; Stephan Budweiser; Frank Heinemann; Michael Pfeifer; Peter Rzehak
Journal:  J Clin Epidemiol       Date:  2008-03-25       Impact factor: 6.437

9.  Correlation of oxidative status with BMI and lung function in COPD.

Authors:  Arpana Vibhuti; Ehtesham Arif; Desh Deepak; Bhawani Singh; M A Qadar Pasha
Journal:  Clin Biochem       Date:  2007-06-02       Impact factor: 3.281

Review 10.  Chronic obstructive pulmonary disease: molecular and cellular mechanisms.

Authors:  P J Barnes; S D Shapiro; R A Pauwels
Journal:  Eur Respir J       Date:  2003-10       Impact factor: 16.671

View more
  4 in total

1.  A Low Peripheral Blood CD4/CD8 Ratio Is Associated with Pulmonary Emphysema in HIV.

Authors:  Matthew Triplette; Engi F Attia; Kathleen M Akgün; Guy W Soo Hoo; Matthew S Freiberg; Adeel A Butt; Cherry Wongtrakool; Matthew Bidwell Goetz; Sheldon T Brown; Christopher J Graber; Laurence Huang; Kristina Crothers
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

Review 2.  The role of CD8 + T lymphocytes in chronic obstructive pulmonary disease: a systematic review.

Authors:  Maya Williams; Ian Todd; Lucy C Fairclough
Journal:  Inflamm Res       Date:  2020-10-10       Impact factor: 4.575

3.  Isorhamnetin Alleviates Airway Inflammation by Regulating the Nrf2/Keap1 Pathway in a Mouse Model of COPD.

Authors:  Yifan Xu; Jing Li; Zhiwei Lin; Weiquan Liang; Lijie Qin; Jiabin Ding; Shuqi Chen; Luqian Zhou
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

4.  Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis.

Authors:  Mingming Deng; Yan Yin; Qin Zhang; Xiaoming Zhou; Gang Hou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.